Stay updated on Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The displayed site revision changed from v3.7.2 to v3.8.0. The page still shows a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T02:27:50.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T03:18:52.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T05:17:23.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T02:59:28.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study content, indicating restricted access to the ClinicalTrials.gov record.
    Difference
    18%
    Check dated 2026-09-21T00:32:13.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page adds a 2015 U.S. NIH grant/contract acknowledgment and updates the revision tag from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T22:22:42.000Z thumbnail image

Stay in the know with updates to Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.